These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 33476315)

  • 1. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    Galloway SE; Paul P; MacCannell DR; Johansson MA; Brooks JT; MacNeil A; Slayton RB; Tong S; Silk BJ; Armstrong GL; Biggerstaff M; Dugan VG
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):95-99. PubMed ID: 33476315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.
    Firestone MJ; Lorentz AJ; Wang X; Como-Sabetti K; Vetter S; Smith K; Holzbauer S; Meyer S; Ehresmann K; Danila R; Lynfield R
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):278-279. PubMed ID: 33630825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
    Paul P; France AM; Aoki Y; Batra D; Biggerstaff M; Dugan V; Galloway S; Hall AJ; Johansson MA; Kondor RJ; Halpin AL; Lee B; Lee JS; Limbago B; MacNeil A; MacCannell D; Paden CR; Queen K; Reese HE; Retchless AC; Slayton RB; Steele M; Tong S; Walters MS; Wentworth DE; Silk BJ
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):846-850. PubMed ID: 34111060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
    Touret F; Luciani L; Baronti C; Cochin M; Driouich JS; Gilles M; Thirion L; Nougairède A; de Lamballerie X
    mBio; 2021 Aug; 12(4):e0085021. PubMed ID: 34225487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
    Gaymard A; Bosetti P; Feri A; Destras G; Enouf V; Andronico A; Burrel S; Behillil S; Sauvage C; Bal A; Morfin F; Van Der Werf S; Josset L; ; ; Blanquart F; Coignard B; Cauchemez S; Lina B
    Euro Surveill; 2021 Mar; 26(9):. PubMed ID: 33663644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
    Ojelade M; Rodriguez A; Gonzalez D; Otokunrin D; Ramachandruni S; Cuevas E; Moon K; Tyler CG; Freeland M; Anderson M; Haire K; Orozco Y; Scipio F; Springer Y; Prot E; Shuford JA
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):348-349. PubMed ID: 33705368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.
    Abe H; Ushijima Y; Bikangui R; Zoa-Assoumou S; Ondo GN; Manouana GP; More A; Skarwan E; Yali-Assy-Oyamli Y; Ndeboko B; Myrabelle Avome Houechenou R; Djoba Siawaya JF; Lell B; Adegnika AA; Yasuda J
    J Med Virol; 2021 Oct; 93(10):6054-6058. PubMed ID: 34185327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.
    Leung K; Shum MH; Leung GM; Lam TT; Wu JT
    Euro Surveill; 2021 Jan; 26(1):. PubMed ID: 33413740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021.
    Feder KA; Pearlowitz M; Goode A; Duwell M; Williams TW; Chen-Carrington PA; Patel A; Dominguez C; Keller EN; Klein L; Rivera-Colon A; Mostafa HH; Morris CP; Patel N; Schauer AM; Myers R; Blythe D; Feldman KA
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):627-631. PubMed ID: 33914724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.
    Van Naarden Braun K; Drexler M; Rozenfeld RA; Deener-Agus E; Greenstein R; Agus M; Joffe M; Kasowitz A; Levy P; Nerwen C
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1420-1424. PubMed ID: 34618796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 - St. Louis, Missouri, January-May 2021.
    Rebmann T; Loux TM; Arnold LD; Charney R; Horton D; Gomel A
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1245-1248. PubMed ID: 34499631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.
    Malden DE; Bruxvoort KJ; Tseng HF; Ackerson B; Choi SK; Florea A; Tubert J; Takhar H; Aragones M; Hong V; Talarico CA; McLaughlin JM; Qian L; Tartof SY
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1415-1419. PubMed ID: 34618801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil.
    Lamarca AP; de Almeida LGP; Francisco RDS; Lima LFA; Scortecci KC; Perez VP; Brustolini OJ; Sousa ESS; Secco DA; Santos AMG; Albuquerque GR; Mariano APM; Maciel BM; Gerber AL; Guimarães APC; Nascimento PR; Neto FPF; Gadelha SR; Porto LC; Campana EH; Jeronimo SMB; Vasconcelos ATR
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009835. PubMed ID: 34644287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 transmissibility compared between variants of concern and vaccination status.
    Wang L; Didelot X; Bi Y; Gao GF
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35062017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals.
    Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG
    Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.
    Gravagnuolo AM; Faqih L; Cronshaw C; Wynn J; Klapper P; Wigglesworth M
    EBioMedicine; 2021 Aug; 70():103540. PubMed ID: 34392145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.